Spread of human cytomegalovirus (HCMV) after infection of human hematopoietic progenitor cells: Model of HCMV latency

Blood

Volumn 90, Issue 6, 1997, Pages 2482-2491

  Zhuravskaya, T ^a   Maciejewski, J P ^a   Netski, D M ^a   Bruening, E ^a   Mackintosh, F R ^a   St Jeor, S ^a  

^a UNIVERSITY OF NEVADA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; GENE PRODUCT;

ARTICLE; CELL MATURATION; CELL PROLIFERATION; CYTOMEGALOVIRUS INFECTION; EMBRYO; HEMATOPOIESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG FIBROBLAST; PATHOPHYSIOLOGY; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; VIRUS ISOLATION; VIRUS LATENCY;

EID: 0030865998     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.6.2482.2482_2482_2491     Document Type: Article

References (48)

1. Jordan M: Latent infection and the elusive cytomegalovirus. Rev Infect Dis 5:205, 1983
2. Taylor-Wiedman J, Sissons JG, Borysiewicz LK, Sinclair J: Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol 72:2059, 1991
3. Taylor-Wiedman JA, Hayhurst GP, Sissons JGP, Sinclair JH: Polimorphonuclear cells are not sites of persistence of human cytomegalovirus in healthy individuals. J Gen Virol 74:265, 1993
4. Alford CA, Britt WJ: Fields Virology-Cytomegalovirus (ed 2). New York, NY, Raven, 1990, p 1981
5. Fiala M, Payne JE, Perne TV, Moore TC, Henle W, Montgomerie JZ, Chaterjee SN, Guze LB: Epidemiology of cytomegalovirus infection after transplantation and immunosuppression. J Infect Dis 132:421, 1975
6. Bowden RA, Floornoy N, Newton B, Banaji M, Thomas ED, Meyers JD: Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation. N Engl J Med 314:1006, 1986
7. Adler S: Transfusion-associated cytomegalovirus infections. Rev Infect Dis 5:977, 1983
8. Betts RF, Freeman RB, Douglas RJ, Talley TE: Clinical manifestations of renal allograft derived primary cytomegalovirus infection. Am J Dis Child 131:759, 1977
9. Chou S: Acquisition of donor strains of cytomegalovirus by renal transplant recipients. N Engl J Med 314:1418, 1986
10. Fox AS, Tolpin MD, Baker AL, Broelsch CE, Whittington PF, Jackson T, Thistlethwaite JR, Stuart FP: Seropositivity in liver transplant recipients as a predictor of cytomegalovirus disease. J Infect Dis 149:207, 1988
11. Preiksaitis JK, Rosno S, Grumet C, Merigan TC: Infections due to herpes viruses in cardiac transplant recipients: Role of the donor heart and immunosuppressive therapy. J Infect Dis 147:974, 1983
12. Kaariainen L, Klemola E, Paloheimo J: Rise of cytomegalovirus antibodies in an infectious mononucleosis-like syndrome after transfusion. Br Med J 1:1270, 1966
13. Lang DJ, Scolnick EM, Willerson JT: Association of cytomegalovirus infection with the postperfusion syndrome. N Engl J Med 278:1147, 1968
14. Hersman J, Meyers JD, Thomas ED, Buckner CD, Clift I: The effect of granulocyte transfusions on the incidence of cytomegalovirus infection after allogenic marrow transplantation. Ann Intern Med 96:149, 1982
15. Lang DJ, Ebert PA, Rodgers BM, Boggess HP, Rixse RS: Reduction of postperfusion cytomegalovirus infections following the use of leukocyte depleted blood. Transfusion 17:391, 1977
16. De Graan-Hentzen YCE, Gratama JW, Mudde GC, Verdonck LF, Houbiers JGA, Brand A, Sebens FW, Van Loon AM, The TH, Willemze R, De Gast GC: Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood products. Transfusion 29:757, 1989
17. Mutter W, Reddehase MF, Busche FW, Buhring HJ, Koszinowski WH: Failure in generating hemopoietic stem cells is the primary cause of death from cytomegalovirus disease in the immunocompromised host. J Exp Med 167:1645, 1988
18. Greffe JMM, van der Giessen M. van der Gun BTF, van Son SJ, The TH: The predominant viral antigen present in peripheral blood leukocytes during an active cytomegalovirus (CMV) infection is the lower matrix protein pp65, in Landini MP (ed): Progress in Cytomegalovirus Research. International Congress Series. Amsterdam, The Netherlands, Excerpta Medica, 1991, p 18
19. Dankner WM, McCutchan JA, Richman DD, Hirata K, Spector SA: Localisation of human cytomegalovirus in peripheral blood leukocytes by in situ hybridization. J Infect Dis 161:31, 1990
20. Howell CL, Miller MJ, Martin WJ: Comparison of rates of virus isolation from leukocyte populations separated from blood by conventional and Ficoll-Paque/Macrodex methods. J Clin Microbiol 10:533, 1979
21. Schrier RD, Nelson JA, Oldstone M: Detection of human cytomegalovirus in peripheral blood lymphocytes in a natural infection. Science 230:1048, 1985
22. Toorkey CB, Carrigan DR: Immunohistochemical detection of an immediate early antigen of human cytomegalovirus in normal tissues. J Infect Dis 160:741, 1989
23. Taylor-Wiedman J, Sissons P, Sinclair J: Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers. J Virol 68:1597, 1994
24. Rice GPA, Schrier RD, Oldstone MBA: Cytomegalovirus infects human lymphocytes and monocytes: Virus expression is limited to immediate-early gene products. Proc Natl Acad Sci USA 81:6134, 1984
25. Scott DM, Rodgers BC, Freeke C, Buiter J, Sissons JGP: Human cytomegalovirus and monocytes: Limited infection and negligible immunosuppression in normal mononuclear cells infected in vitro with mycoplasma free strains. J Gen Virol 70:658, 1989
26. Einhorn L, Ost A: Cytomegalovirus infection of human blood cells. J Infect Dis 149:207, 1984
27. Ibanez CE, Schrier P, Ghazal P, Wiley CA, Nelson JA: Human cytomegalovirus productively infects primary differentiated macrophages. J Virol 65:6581, 1991
28. Lathey JL, Spector SA: Unrestricted replication of human cytomegalovirus in hydrocortisone-treated macrophages. J Virol 65:6371, 1991
29. Minton EJ, Tysoe C, Sinclair JH, Sissons JBP: Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow. J Virol 68:4017, 1994
30. Verdonck LF, VanHeugten H, deGast GC: Delay in platelet recovery after bone marrow transplantation: Impact on of cytomegalovirus infection. Blood 66:921, 1985
31. Sing GK, Ruscetti FW: Preferential suppression of myelopoiesis in normal human bone marrow cells after in vitro challenge with human cytomegalovirus. Blood 75:1965, 1990
32. Chesney PJ, Taher A, Gilbert EMF, Shahidi NY: Intranuclear inclusions in megacaryocytes in congenital cytomegalovirus infection. J Pediatr 92:957, 1979
33. Foster KM, Jack I: A prospective study of the role of cytomegalovirus in post-transfusion mononucleosis. N Engl J Med 280:1311, 1969
34. Risdall RJ, Mckenna RW, Nesbit ME, Krivit W, Balfour HH, Simmons RL, Brunning RD: Virus-associated hemophagocytic syndrome. Cancer 44:993, 1979
35. Simmons P, Kaushansky K, Torok-Storb B: Mechanisms of cytomegalovirus-mediated myelosuppression: Perturbation of stromal cell function versus direct infection of myeloid cells. Proc Natl Acad Sci USA 87:1386, 1990
36. Winston DJ, Ho WG, Lin CH, Budinger MD, Champlin RE, Gale RP: Delay in platelet recovery after bone marrow transplantation: Impact of cytomegalovirus infection. Am J Med 106:128, 1984
37. Verdonck LF, van Heugten H, de Gast GC, Nieuwenhuis HK, Dekker AW: Cytomegalovirus infection causes delayed platelet recovery after bone marrow transplantation. Blood 78:844, 1991
38. Rakusan TA, Juneja HS, Fleishman WR: Inhibition of hemopoietic colony formation by human cytomegalovirus in vitro. J Infect Dis 159:127, 1989
39. MacKintosh FR, Adlish J, Hall SW, St Jeor S, Smith E, Tavassoli M, Zanjani ED: Suppression of normal human hematopoiesis by cytomegalovirus in vitro. Exp Hematol 21:243, 1993
40. St Jeor SC, Rapp F: Replication of cytomegalovirus in cells pretreated with 5-iodo-2′-deoxyuridine. J Virol 11:686, 1973
41. Chomchinski P, Sacchi N: Single-step method of RNA isolation by acid-guanidinum thiocyanate-phenol-chlorophorm extraction. Anal Biochem 162:156, 1987
42. Maciejewski JP, Bruening EE, Donahue RE, Mocarski ES, St Jeor S: Infection of hematopoietic progenitor cells by human cytomegalovirus. Blood 80:170, 1992
43. Kondo K, Kaneshima H, Mocarski ES: Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc Natl Acad Sci USA 91:11879, 1990
44. Sodeberg C, Larson S, Bergstedt-Lindquist S, Moller E: Definition of a subset of human peripheral blood mononuclear cells that are permissive to human cytomegalovirus infection. J Virol 67:3166, 1993
45. Preiksaitis JK, Janowska A: Persistence of human cytomegalovirus in human long-term bone marrow culture: Relationship to hemopoiesis. J Med Virol 35:76, 1991
46. Reiser H, Kuhn J, Doerr HW, Kirchner H, Munk K, Braun R: Human cytomegalovirus replicates in human primary bone marrow cells. J Gen Virol 67:2595, 1986
47. Fish KN, Depto AS, Moses AV, Britt W, Nelson JA: Growth kinetics of human cytomegalovirus are altered in monocyte-derived macrophages. J Virol 69:3737, 1995
48. Brenner CA, Tam AW, Nelson PA, Engleman EG, Suzuki N, Fry KE, Larrick JW: Message amplification phenotyping (MAP-Ping): A technique to simultaneously measure multiple mRNAs from a small number of cells. Biotechniques 7:1096, 1989